“…Evidence indicates that DTPs are effective at treating adults with anorexia nervosa and bulimia nervosa through reducing eating disorder psychopathology and disordered behaviours, restoring patients’ weight, and reducing anxiety and depression (Abbate-Daga et al , 2015; Beintner et al , 2019; Ben-Porath et al , 2010; Brown et al , 2018; Crino and Djokvucic, 2010; Fittig et al , 2008; Freudenberg et al , 2016; Garte et al , 2015; Hepburn and Clark-Stone, 2016; Jones et al , 2007; Kong, 2005; Olmsted et al , 2003, 2013; Reisch et al , 2001; Schaffner and Buchanan, 2008; Wade et al , 2019; Willinge et al , 2010; Zipfel et al , 2002). Although symptom frequencies often remain within the clinical parameters specified by the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (American Psychiatric Association, 2013) at the end of day treatment (Hepburn and Wilson, 2014), evidence suggests that treatment gains can be maintained or further improved at 3 months (Wade et al , 2019 ; Willinge et al , 2010), 6 months (Reisch et al , 2001), 12 months (Abbate-Daga et al , 2015), 18 months (Fittig et al , 2008), 24 months (Brown et al , 2018) and 26 months (Beintner et al , 2019).…”